Proactive Investors - Run By Investors For Investors

Thursday's followed - global share sell off and contrary Tesla

The turmoil in global equities and the oil price slide continues....and in other news...
Thursday's followed - global share sell off and contrary Tesla
Shares in the tech/ automobile firm added over 6% in New York today and surged after hours

The turmoil in global equities and the oil price slide  continues - with West Texas Intermediate -  now hovering around the US$27 mark - below what was called the last "pyschological" cut-off of US$30.

It is a topsy turvy world indeed currently, so no surprise perhaps then, that  luxury car maker Tesla (NASDAQ:TSLA) - and Elon Musk baby -  throws out another curved ball today.

Shares in the tech/ automobile firm added over 6% in New York and surged after hours after it posted quarterly earnings, which sent out a myriad of mixed fumes (although of course it didn't, cos it's electric vehicles).

On the one hand, the quarterly figures were disappointing, and less than analysts had hoped,  with an adjusted loss of 87 cents per share on US$1.75bln in sales.

But on the other there was positive news on production targets for this year and for those that follow the firm closely, exciting news that the new Model 3 vehicle will go on sale from March 31.

This is the first "moderately" priced electric car, which some  may be surprised to hear has a starting price of US$35,000.

Tesla also said it expects to ship 80,000 to 90,000 Model S and Model X cars in 2016, beating forecasts that the company would only ship about 76,000.

So what else was going on?

Junior biotech Neurotrope (OTCMKTS:NTRP) shares edged up 2.5% as it had some news on a potential treatment for devastating Alzheimer’s disease.

First patients have been dosed in its phase 2b clinical trial of lead candidate Bryostatin-1 for the advanced form of the disease.

The company expects to report three month interim data during the first quarter of 2017 with complete six month data set expected during the first half of 2017.


Tesla Motors (NASDAQ:TSLA) accelerates 6.5% to US$152.96 atfre the automaker gave a forecast for deliveries of its Model X that topped analyst estimates, and also said it expected to be profitable this year.

Expedia (NASDAQ:EXPE) jumps 8.2% to US$102.05 after giving an upbeat 2016 profit forecast.

Tripadvisor (NASDAQ:TRIP) soars 15.6% to US$62.85 after reporting adjusted quarterly profit and revenue above estimates. It benefited from higher ad sales and an increase in subscriptions.


Monster Worldwide (NYSE:MWW) cascades 34% to US$2.82 as it reported a decline in sales for its fourth quarter, which were worse than analysts had feared.

Twitter drops (NYSE:TWTR) 4.3% to US$14.33 after the key metric of monthly average users fell, and the company gave current quarter revenue guidance that falls below Street forecasts.

SolarCity (NASDAQ:SCTY) extends Wednesdays to fall a further 7.8% to US$17.18 after chief financial officer Brad Buss resigned, replaced by SolarCity President Tanguy Serra, in wake of poorly received 2015 earnings.



View full NTRP profile View Profile

Neurotrope Timeline

Related Articles

seeds in a bowl
March 07 2019
The Vancouver company is developing Omega-3 products as oil, powder or emulsion to be used as food additives
man with erectile dysfunction
June 17 2019
Headline results from the trial of MED2005 are due before the end of 2019, while Futura is also confident of hearing back from UK regulators about its pain relief gel later in the year
January 15 2019
Under former chief executive Peter George and his successor Shaun Chilton, Clinigen has been transformed via a series of well-judged, quickly integrated and cash generative acquisitions
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use